Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Malvy

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 6, 2006
Innovative nanotechnologies for the delivery of oligonucleotides and siRNAN Toub, C Malvy, E Fattal, et al.
Antisense Research and Development|January 1, 1994
Retroviral inhibition by antisense oligonucleotides determined by intracellular stabilityC Ropert, A Okruszek, P Couvreur, et al.
Biochemical and Biophysical Research Communications|January 15, 1990
Structural features associated with alpha- anomeric in oligo-alpha-thymidylatesJ R Bertrand, D Bazile, C Malvy, et al.
Journal of Biomolecular Structure & Dynamics|December 1, 1991
Molecular modelling of 9-aminoellipticine interactions with abasic oligonucleotidesR Letellier, E Taillandier, J R Bertrand, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 4, 2008
Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNAH de Martimprey, C Vauthier, C Malvy, et al.
Toxicology and Applied Pharmacology|June 30, 1987
In vivo exposure to four ellipticine derivatives with topoisomerase inhibitory activity results in chromosome clumping and sister chromatid exchange in murine bone marrow cellsG Renault, C Malvy, W Venegas, et al.
Anti-Cancer Drug Design|March 1, 1988
Involvement of apurinic sites in the synergistic action of alkylating and intercalating drugs in Escherichia coliC Malvy, H Safraoui, E Bloch, et al.
Nucleic Acids Research|January 15, 1996
Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotorF Svinarchuk, A Debin, J R Bertrand, et al.
Biochimie|October 6, 2000
Modified alkaline elution allows the measurement of intact apurinic sites in mammalian genomic DNAC Malvy, M Lefrançois, J R Bertrand, et al.
Biochemical and Biophysical Research Communications|March 16, 1992
Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirusC Ropert, M Lavignon, C Dubernet, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 6, 2006
Innovative nanotechnologies for the delivery of oligonucleotides and siRNAN Toub, C Malvy, E Fattal, et al.
Antisense Research and Development|January 1, 1994
Retroviral inhibition by antisense oligonucleotides determined by intracellular stabilityC Ropert, A Okruszek, P Couvreur, et al.
Biochemical and Biophysical Research Communications|January 15, 1990
Structural features associated with alpha- anomeric in oligo-alpha-thymidylatesJ R Bertrand, D Bazile, C Malvy, et al.
Journal of Biomolecular Structure & Dynamics|December 1, 1991
Molecular modelling of 9-aminoellipticine interactions with abasic oligonucleotidesR Letellier, E Taillandier, J R Bertrand, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 4, 2008
Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNAH de Martimprey, C Vauthier, C Malvy, et al.
Toxicology and Applied Pharmacology|June 30, 1987
In vivo exposure to four ellipticine derivatives with topoisomerase inhibitory activity results in chromosome clumping and sister chromatid exchange in murine bone marrow cellsG Renault, C Malvy, W Venegas, et al.
Anti-Cancer Drug Design|March 1, 1988
Involvement of apurinic sites in the synergistic action of alkylating and intercalating drugs in Escherichia coliC Malvy, H Safraoui, E Bloch, et al.
Nucleic Acids Research|January 15, 1996
Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotorF Svinarchuk, A Debin, J R Bertrand, et al.
Biochimie|October 6, 2000
Modified alkaline elution allows the measurement of intact apurinic sites in mammalian genomic DNAC Malvy, M Lefrançois, J R Bertrand, et al.
Biochemical and Biophysical Research Communications|March 16, 1992
Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirusC Ropert, M Lavignon, C Dubernet, et al.
Pageof 6